Aurobindo Pharma Limited is pleased to announce that the company has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Ondansetron Injection USP 2rng/mL packaged in 40mg/20mL Multiple-dose Vials (ANDA 202599) and Ondansetron Injection USP 2mg/mL packaged in 4mg/2mL Single-dose Vials, Preservative-free (ANDA 202600). The products are ready for launch.
New Delhi, June 28 2013: The Cabinet Committee on Economic Affairs today approved the continuation of the National Mission on Food Processing (NMFP) for the remainder of 12th Five Year Plan (2013-17) based on detailed proposals submitted by the Ministry of Food Processing Industries (MOFPI).
The NMFP outlay for 2012-17 has been kept at Rs. 1,600 crore consisting of Rs. 1,250 crore provided by the Government of India (GOI) and corresponding State share of Rs. 350 crore. This includes Rs. 320 crore already approved for 2012-13, of which Rs. 250 crore was the GOI share and Rs. 70 crore was the State share.
The following schemes under the NMFP will be implemented by State Governments for the remainder of 12th Five Year Plan in pursuance of today's approval:
i. Scheme for technology up-gradation / establishment / modernisation of food processing industries.